Effect of ceruletide on epileptogenesis in amygdaloid kindled rats

Yoshitaka Yamamoto, Toshifumi Itano, Osamu Miyamoto, Masaaki Tokuda, Hideki Matsui, Najma A. Janjua, Hiroshi Suwaki, Yasushi Okada, Tetsuro Negi, Tetuhide H. Murakami, Osamu Hatase

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The inhibitory effects of ceruletide (CLT), a cholecystokinin-8 (CCK)-like, peptide, were investigated in the epileptogenesis in the amygdaloid kindled rats. Lower doses of CLT (20-80 μg/kg) inhibited the progression of kindling process. After acquiring C5 stage, a higher dose (160 μg.kg) was required to suppress the seizure susceptibility. These results, in light of several previous studies showing no serious side effects, suggest that CLT might be useful as an anti-epileptogenic agent for clinical usage.

Original languageEnglish
Pages (from-to)353-356
Number of pages4
JournalBrain Research
Volume630
Issue number1-2
DOIs
Publication statusPublished - Dec 10 1993
Externally publishedYes

Fingerprint

Ceruletide
Seizures
Peptides

Keywords

  • CCK
  • Ceruletide
  • Epilepsy
  • Kindling

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Yamamoto, Y., Itano, T., Miyamoto, O., Tokuda, M., Matsui, H., Janjua, N. A., ... Hatase, O. (1993). Effect of ceruletide on epileptogenesis in amygdaloid kindled rats. Brain Research, 630(1-2), 353-356. https://doi.org/10.1016/0006-8993(93)90678-G

Effect of ceruletide on epileptogenesis in amygdaloid kindled rats. / Yamamoto, Yoshitaka; Itano, Toshifumi; Miyamoto, Osamu; Tokuda, Masaaki; Matsui, Hideki; Janjua, Najma A.; Suwaki, Hiroshi; Okada, Yasushi; Negi, Tetsuro; Murakami, Tetuhide H.; Hatase, Osamu.

In: Brain Research, Vol. 630, No. 1-2, 10.12.1993, p. 353-356.

Research output: Contribution to journalArticle

Yamamoto, Y, Itano, T, Miyamoto, O, Tokuda, M, Matsui, H, Janjua, NA, Suwaki, H, Okada, Y, Negi, T, Murakami, TH & Hatase, O 1993, 'Effect of ceruletide on epileptogenesis in amygdaloid kindled rats', Brain Research, vol. 630, no. 1-2, pp. 353-356. https://doi.org/10.1016/0006-8993(93)90678-G
Yamamoto Y, Itano T, Miyamoto O, Tokuda M, Matsui H, Janjua NA et al. Effect of ceruletide on epileptogenesis in amygdaloid kindled rats. Brain Research. 1993 Dec 10;630(1-2):353-356. https://doi.org/10.1016/0006-8993(93)90678-G
Yamamoto, Yoshitaka ; Itano, Toshifumi ; Miyamoto, Osamu ; Tokuda, Masaaki ; Matsui, Hideki ; Janjua, Najma A. ; Suwaki, Hiroshi ; Okada, Yasushi ; Negi, Tetsuro ; Murakami, Tetuhide H. ; Hatase, Osamu. / Effect of ceruletide on epileptogenesis in amygdaloid kindled rats. In: Brain Research. 1993 ; Vol. 630, No. 1-2. pp. 353-356.
@article{08cc5c081c0e484b8ba45358768b195b,
title = "Effect of ceruletide on epileptogenesis in amygdaloid kindled rats",
abstract = "The inhibitory effects of ceruletide (CLT), a cholecystokinin-8 (CCK)-like, peptide, were investigated in the epileptogenesis in the amygdaloid kindled rats. Lower doses of CLT (20-80 μg/kg) inhibited the progression of kindling process. After acquiring C5 stage, a higher dose (160 μg.kg) was required to suppress the seizure susceptibility. These results, in light of several previous studies showing no serious side effects, suggest that CLT might be useful as an anti-epileptogenic agent for clinical usage.",
keywords = "CCK, Ceruletide, Epilepsy, Kindling",
author = "Yoshitaka Yamamoto and Toshifumi Itano and Osamu Miyamoto and Masaaki Tokuda and Hideki Matsui and Janjua, {Najma A.} and Hiroshi Suwaki and Yasushi Okada and Tetsuro Negi and Murakami, {Tetuhide H.} and Osamu Hatase",
year = "1993",
month = "12",
day = "10",
doi = "10.1016/0006-8993(93)90678-G",
language = "English",
volume = "630",
pages = "353--356",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Effect of ceruletide on epileptogenesis in amygdaloid kindled rats

AU - Yamamoto, Yoshitaka

AU - Itano, Toshifumi

AU - Miyamoto, Osamu

AU - Tokuda, Masaaki

AU - Matsui, Hideki

AU - Janjua, Najma A.

AU - Suwaki, Hiroshi

AU - Okada, Yasushi

AU - Negi, Tetsuro

AU - Murakami, Tetuhide H.

AU - Hatase, Osamu

PY - 1993/12/10

Y1 - 1993/12/10

N2 - The inhibitory effects of ceruletide (CLT), a cholecystokinin-8 (CCK)-like, peptide, were investigated in the epileptogenesis in the amygdaloid kindled rats. Lower doses of CLT (20-80 μg/kg) inhibited the progression of kindling process. After acquiring C5 stage, a higher dose (160 μg.kg) was required to suppress the seizure susceptibility. These results, in light of several previous studies showing no serious side effects, suggest that CLT might be useful as an anti-epileptogenic agent for clinical usage.

AB - The inhibitory effects of ceruletide (CLT), a cholecystokinin-8 (CCK)-like, peptide, were investigated in the epileptogenesis in the amygdaloid kindled rats. Lower doses of CLT (20-80 μg/kg) inhibited the progression of kindling process. After acquiring C5 stage, a higher dose (160 μg.kg) was required to suppress the seizure susceptibility. These results, in light of several previous studies showing no serious side effects, suggest that CLT might be useful as an anti-epileptogenic agent for clinical usage.

KW - CCK

KW - Ceruletide

KW - Epilepsy

KW - Kindling

UR - http://www.scopus.com/inward/record.url?scp=0027386167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027386167&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(93)90678-G

DO - 10.1016/0006-8993(93)90678-G

M3 - Article

C2 - 8118705

AN - SCOPUS:0027386167

VL - 630

SP - 353

EP - 356

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -